Health

Results: 289-300 of 10101

Business Wire associated0

Global Myeloma Experts Define Cure as New Approaches to Treatment Advance

PR Newswire associated0

Newronika Announces First Participant Implanted in ADVENT Pivotal Study

EQT Foundation commits more than €1 million to help unlock new ways of delivering medicines to the brain

PR Newswire associated0

Leads To Development Joins Clarenta Group, Strengthening Early-Stage Drug Development Expertise

Visit Roquette at booth 1A18 in the excipients hall.

Roquette to Showcase End-to-End Pharma Solutions for Patient-Centric Formulations at CPHI Milan 2026

Change in number of shares and votes in Sobi

PR Newswire associated0

Roche launches newborn screening test for three severe genetic conditions

Business Wire logo

EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis

Business Wire logo

Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026

Business Wire logo

Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill

New study reveals major impact of climate change on skin health worldwide

PR Newswire associated0

Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility